Complementary analysis of proteome-wide proteomics reveals changes in RNA binding protein-profiles during prostate cancer progression.
暂无分享,去创建一个
L. Latonen | E. Niskanen | N. Sadeesh | Sonja Koivukoski | Erika Aikio | Elina Kallio | Leena Latonen
[1] D. Qi,et al. RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway , 2022, Cell Communication and Signaling.
[2] Y. Minami,et al. c-Src–mediated phosphorylation and activation of kinesin KIF1C promotes elongation of invadopodia in cancer cells , 2022, The Journal of biological chemistry.
[3] P. Xie,et al. Neddylation modification of the U3 snoRNA-binding protein RRP9 by Smurf1 promotes tumorigenesis , 2021, The Journal of biological chemistry.
[4] L. Latonen,et al. Proteomic Landscape of Prostate Cancer: The View Provided by Quantitative Proteomics, Integrative Analyses, and Protein Interactomes , 2021, Cancers.
[5] Jaana M. Hartikainen,et al. Chromatin-directed proteomics-identified network of endogenous androgen receptor in prostate cancer cells , 2021, Oncogene.
[6] Li Yang,et al. Effect of eukaryotic translation initiation factor 4A3 in malignant tumors , 2021, Oncology letters.
[7] L. Latonen,et al. Androgen-Driven Fusion Genes and Chimeric Transcripts in Prostate Cancer , 2021, Frontiers in Cell and Developmental Biology.
[8] T. H. van der Kwast,et al. Prostate cancer , 2021, Nature Reviews Disease Primers.
[9] Xian Du,et al. An emerging role of chromatin-interacting RNA-binding proteins in transcription regulation. , 2020, Essays in biochemistry.
[10] Levi Waldron,et al. HGNChelper: identification and correction of invalid gene symbols for human and mouse , 2020, bioRxiv.
[11] E. Markert,et al. 2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer , 2020, Nature Communications.
[12] R. Irizarry. ggplot2 , 2019, Introduction to Data Science.
[13] P. Sorensen,et al. Pharmacological systems analysis defines EIF4A3 functions in cell-cycle and RNA stress granule formation , 2019, Communications Biology.
[14] Natalie S. Fox,et al. The Proteogenomic Landscape of Curable Prostate Cancer. , 2019, Cancer cell.
[15] Chunling Yuan,et al. Systematic Analysis of Gene Expression Alteration and Co-Expression Network of Eukaryotic Initiation Factor 4A-3 in Cancer , 2018, Journal of Cancer.
[16] M. Nykter,et al. Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression , 2018, Nature Communications.
[17] M. Rubin,et al. The Genomics of Prostate Cancer: emerging understanding with technologic advances , 2018, Modern Pathology.
[18] A. Flores-Morales,et al. Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer , 2017, Front. Oncol..
[19] K. Fukuda,et al. Discovery of Novel 5-(Piperazine-1-carbonyl)pyridin-2(1H)-one Derivatives as Orally eIF4A3-Selective Inhibitors. , 2017, ACS medicinal chemistry letters.
[20] A. Ridley,et al. The RNA‐binding protein LARP4 regulates cancer cell migration and invasion , 2016, Cytoskeleton.
[21] Roland Eils,et al. Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..
[22] Evan O. Paull,et al. Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer , 2016, Cell.
[23] Ronald J. Moore,et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer , 2016, Cell.
[24] Pär Stattin,et al. The Proteome of Primary Prostate Cancer. , 2016, European urology.
[25] Michael L. Gatza,et al. Proteogenomics connects somatic mutations to signaling in breast cancer , 2016, Nature.
[26] Xintao Wei,et al. Resources for the comprehensive discovery of functional RNA elements , 2015, bioRxiv.
[27] V. Arora,et al. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer , 2015, Nature Reviews Cancer.
[28] S. Blagden,et al. The La-Related Proteins, a Family with Connections to Cancer , 2015, Biomolecules.
[29] M. Mathews,et al. The translation factor eIF5A and human cancer. , 2015, Biochimica et biophysica acta.
[30] Peter Hoffmann,et al. Proteomic developments in the analysis of formalin-fixed tissue. , 2015, Biochimica et biophysica acta.
[31] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[32] S. Gerstberger,et al. A census of human RNA-binding proteins , 2014, Nature Reviews Genetics.
[33] Jeffrey R. Whiteaker,et al. Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.
[34] Jinzhong Lin,et al. Structural and functional analysis of the U3 snoRNA binding protein Rrp9. , 2013, RNA.
[35] Norman E. Davey,et al. Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins , 2012, Cell.
[36] M. Sadar,et al. FUS/TLS Is a Co-Activator of Androgen Receptor in Prostate Cancer Cells , 2011, PloS one.
[37] John T. Wei,et al. Transcriptome Sequencing Identifies PCAT-1, a Novel lincRNA Implicated in Prostate Cancer Progression , 2011, Nature biotechnology.
[38] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[39] Kai-Wei Chang,et al. RNA-binding proteins in human genetic disease. , 2008, Trends in genetics : TIG.
[40] V. Vasiliou,et al. Polymorphisms of Human Aldehyde Dehydrogenases , 2000, Pharmacology.
[41] C. Pellizas,et al. Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions. , 2017, Pathology, research and practice.
[42] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.